EIF4E and cancer: 4EGI-1, a small molecular compound targeting to inhibit eIF4E-eIF4G binding, can reduce the expression of c-Myc without affecting the expression of β-actin (173) and has been proved to play an anti-cancer role in human cancer cells (187) without obvious toxicity (175).